Trump’s Doctors Admit to Omitting Serious Information in Initial Report About His Health

President Donald Trump‘s doctors are admitting to not telling the full story about his health at first.

Dr. Sean P. Conley gave an update about Trump‘s health on Sunday (October 4), and acknowledged that they gave an overly positive description a day before, the New York Times reports.

PHOTOS: Check out the latest pics of Donald Trump

“I didn’t want to give any information that might steer the course of illness in another direction, and in doing so, you know, it came off that we were trying to hide something, which wasn’t necessarily true,” he explained.

The doctors then said that Trump had a “high fever” on Friday (October 2) and a second incident on Saturday (October 3) where his oxygen levels dropped. They were not clear whether he was administered oxygen again.

Dr. Conley also said that the president had also been given the steroid dexamethasone.


Read More

Taat Lifestyle And Wellness’ Beyond Tobacco – An Initial Review (OTCMKTS:TOBAF)


While the usage of cigarettes has declined dramatically over the last several decades, the fact remains that there are still 5.3 trillion cigarettes sold annually, world-wide, which translates into 265 billion packs. The average price today is $6.65 per pack, which generates annual revenues, world-wide, of $1,762 trillion.

E-cigarettes have been marketed as a safer alternative to regular cigarettes. However, the fact is that vaping products do contain Nicotine, which of course, is very addictive. E-cigarettes have been linked to increased blood pressure, heart disease, gum infection, lung disease, as well as brain development effects. And yet, according to a recent Gallop Poll, 20% of people age 18-29 vape, compared to 9% in the 30-49 age bracket. According to the World Health Organization, 41 million people used e-cigarettes in 2018 and it is projected that this number will grow to an estimated 55 million by next year.


Read More

CDC advisory panel will not vote on initial COVID-19 vaccine roll-out yet

(Reuters) – The U.S. Centers for Disease Control and Prevention said on Tuesday its planned advisory committee meeting on the allocation of the initial limited doses of a potential COVID-19 vaccine would not include voting on who will get the first shots.

The Advisory Committee on Immunization Practices, a group of external medical experts that advises the CDC, was expected to vote on Tuesday on a plan to prioritize initial doses of any vaccine that proves safe and effective in clinical trials.

However, a spokeswoman for the agency told Reuters that no voting is planned for the session.

The committee may wait until government officials authorize a specific vaccine or vaccines for use before voting on how to give priority to initial doses, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

The vaccine distribution is recommended to occur in a phased manner, with healthcare

Read More